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ABSTRACT We used the substituted-cysteine-accessibility method to identify the channel-lining residues in a region
(257-261) near the putative cytoplasmic end of the M2 membrane-spanning segment of the rat y-aminobutyric acid type A
(GABA,,) receptor a1 subunit. The residues ajVal257 and a1Thr261 were accessible to charged, sulfhydryl-specific reagents
applied extracellularly in both the open and closed states. The accessibility of a1V257C and alT261C in the closed state
implies that the gate must be at least as close to the cytoplasmic end of the channel as ajVal257. Also, the positively charged
reagent methanethiosulfonate ethylammonium penetrated from the extracellular end of the channel to a1T261 C, with which
it reacted, indicating that the anion-selectivity filter is closer to the cytoplasmic end of the channel than this residue is.
Co-application of picrotoxin prevented the sulfhydryl reagents from reacting with a1V257C but did not prevent reaction with
the more extracellular residue a1T261 C. Picrotoxin protection of a1V257C may be due to steric block by picrotoxin bound in
the channel at the level of a1Val257; however, if this protection is allosteric, it is not due to the induction of the resting closed
state in which a1V257C was accessible to sulfhydryl reagent.
INTRODUCTION
,y-Aminobutyric acid type A (GABAA) receptors, the major
inhibitory neurotransmitter receptors in the central nervous
system, are members of a ligand-gated ion channel super-
family (Schofield et al., 1987; Wisden and Seeburg, 1992;
Cully et al., 1994). The binding of GABA to GABAA
receptors induces the opening of an anion-selective channel
that remains open for tens of milliseconds before it closes
(Bormann et al., 1987; Amin and Weiss, 1993; Maconochie
et al., 1994; Macdonald and Olsen, 1994). The GABAA
receptor binds and is inhibited by epileptogenic agents such
as picrotoxin, and cyclodiene insecticides such as dieldrin,
(Twyman et al., 1989, 1992; Porter et al., 1992; Macdonald
and Olsen, 1994; Nagata et al., 1994). Picrotoxin and the
cyclodiene insecticides act as noncompetitive inhibitors of
GABA-induced currents (Maksay and Ticku, 1985; ffrench-
Constant et al., 1993a,b). The location of the picrotoxin
binding site is controversial (Macdonald and Olsen, 1994):
Picrotoxin may bind in the channel lumen and act as an
open channel blocker (Inoue and Akaike, 1988; Gurley et
al., 1995), or picrotoxin may inhibit channel function
allosterically (Smart and Constanti, 1986; Newland and
Cull-Candy, 1992; Yoon et al., 1993). Consistent with either
mechanism is the finding that resistance among insects to
cyclodiene insecticides and to picrotoxin is associated with
a point mutation of the alanine aligned with rat a,Val257 to
serine (see Fig. 1) (ffrench-Constant et al., 1993a,b). To
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investigate the mechanism of picrotoxin block of the
GABAA channel, we have applied the substituted-cysteine-
accessibility method to a region near the cytoplasmic end of
the M2 membrane-spanning segment (257 to 261) of the rat
GABAA a1 subunit.
Hydropathy analysis of GABAA receptor subunit se-
quences predicts that the N-terminal 200-300 amino acids
are extracellular; three closely spaced hydrophobic seg-
ments (Ml, M2, and M3) span the membrane; a loop of
variable length is cytoplasmic; a fourth hydrophobic seg-
ment (M4) spans the membrane; and the C-terminal seg-
ment is extracellular (Olsen and Tobin, 1990; Wisden and
Seeburg, 1992). Based on homology with the nicotinic
acetylcholine receptor (Karlin, 1993; Unwin, 1993),
GABAA receptors are likely formed by five subunits ar-
ranged in a pseudosymmetrical ring around a central ion
channel. The ion channel is presumably lined by residues
from the membrane-spanning segments.
Using the substituted-cysteine-accessibility method
(Akabas et al., 1992, 1994), we previously identified
a1Thr268 and a11le271, two residues near the extracellular
end of the GABAA receptor a1 subunit M2 membrane-
spanning segment, that line the channel (Xu and Akabas,
1993). The substituted-cysteine-accessibility method pro-
vides a systematic approach to the identification of residues
lining an ion channel (Akabas et al., 1992, 1994). In this
method, consecutive residues in putative channel-lining,
membrane-spanning segments are mutated to cysteine, one
at a time. Each cysteine-substitution mutant is expressed in
Xenopus oocytes, and if it has near-normal function the
susceptibility of the engineered cysteine to chemical mod-
ification by charged, sulfhydryl-specific reagents is deter-
mined. We assume that only engineered-cysteine residues
exposed in the channel will be accessible for modification
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by the sulfhydryl reagents; those that face the interior of the
protein or the lipid bilayer will not be accessible to react
with charged, hydrophilic, lipophobic reagents. We infer
that for a mutant receptor whose conduction is irreversibly
altered by the sulfhydryl-specific reagents, the side chain of
the corresponding wild-type residue lines the ion channel.
The sulfhydryl reagents we have used include the nega-
tively charged 4-chloromercuribenzenesulfonate (pCMBS-)
and the positively charged methanethiosulfonate-ethylammo-
nium (CH3SO2SCH2CH2NH3+) (MTSEA+) (Akabas et al.,
1992; Stauffer and Karlin, 1994). pCMBS- adds a mercu-
ribenzenesulfonate moiety to free sulfhydryls and MTSEA+
adds -SCH2CH2NH3' to free sulfhydryls to form a mixed
disulfide. MTSEA+ is at least 2500 times more soluble in
water than in n-octanol (Akabas et al., 1992).
We report that the side chains of the residues alVal257
and a,Thr261 are exposed in the channel in both the open
and closed states of the receptor. We infer that the gate and
the anion-selectivity filter are located near the cytoplasmic
end of the channel. Picrotoxin protects a1V257C from mod-
ification by sulfhydryl reagents but does not protect the
more extracellular residue alT261C. Finally, we infer that
the picrotoxin blocked state is different from the closed state
of the channel.
MATERIALS AND METHODS
Oligonucleotide-mediated mutagenesis
The cDNAs encoding the rat a1 and 72 subunits in the pBluescript SK(-)
plasmid (Stratagene) were obtained from Dr. P. Seeburg (Shivers et al.,
1989; Ymer et al., 1989), and the I3, subunit in the pBluescript SK vector
were obtained from Dr. A. Tobin (Khrestchatisky et al., 1989). The
Altered-sites Mutagenesis procedure (Promega) was used to substitute
cysteine residues, one at a time, in the a1 subunit (see Fig. 1). The a1
cDNA was excised from a1-pBluescript plasmid by restriction digestion
with EcoRI and KpnI and ligated into the pAlter-1 plasmid. Following
mutagenesis a cassette defined by the restriction enzyme sites for NsiI and
BstEII was excised and ligated into wild-type a1-pBluescript plasmid.
Mutations were identified by restriction digestion and confirmed by DNA
sequencing.
Preparation of mRNA and oocytes
For in vitro mRNA transcription, the plasmids containing the al and I38
subunits were linearized with HindIll and the ^y2 subunit was linearized
with XbaI. Messenger RNA was synthesized, and oocytes from Xenopus
laevis were prepared and maintained as described previously (Xu and
Akabas, 1993). One day after the oocytes were harvested, they were
injected with 50 nl mRNA (200 pg/nl) mixed in the ratio of 1:1:1 (al:/31:
7y2). Experiments were performed 2-5 days after mRNA injection.
Reagents
MTSEA+ was synthesized as described previously (Stauffer and Karlin,
1994) and used at a concentration of 2.5 mM. pCMBS- was obtained from
Sigma (St. Louis, MO) and used at a concentration of 0.5 mM. a-Isopro-
pyl-a-methyl-,y-butyrolactone (aIMGBL) and 13-ethyl-f3-methyl-'y-butyro-
lactone (,3EMGBL) were synthesized as described previously (Canney et
al., 1991). Picrotoxin was obtained from Sigma.
Electrophysiology
GABA-induced currents were recorded from individual oocytes under
two-electrode voltage-clamp, at a holding potential of -80 mV. Electrodes
were filled with 3 M KCl and had a resistance of <2 megaohms. The
ground electrode was connected to the chamber via a 3 M KCl/agar bridge.
Data were acquired into a 486/33 MHz computer using a TEV-200 am-
plifier (Dagan Instruments, Minneapolis, MN) and a TL1-DMA data
interface (Axon Instruments, Foster City, CA), and software was written
using the Axobasic language (Axon Instruments). The oocyte was perfused
at 5 ml/min with Ca2+-free Frog Ringer solution (CFFR) (115 mM NaCl,
2.5 mM KCl, 1.8 mM MgCl2, 10 mM HEPES, pH 7.5, with NaOH) at
room temperature.
Experimental protocol
We tested the susceptibility of wild-type and mutant GABAA receptors to
a 1-min application of the sulfhydryl reagents applied in the presence or
absence of 100 ,uM GABA. The following sequence of perfusing solutions
was used: 100 ,uM GABA (10 s), CFFR (3 min), 100 ,uM GABA (10 s),
CFFR (3 min), sulfhydryl reagent ± 100 ,uM GABA (1 min), CFFR (3
min), 100 ,uM GABA (10 s), CFFR (3 min), and 100 ,uM GABA (10 s)
(see Fig. 2 for example). The average of the two peak currents before the
sulfhydryl reagent was applied was compared with the average of the two
peak currents after. The fractional effect was taken as [1 - (IGABA, afez/
IGABA, before)]. The sulfhydryl reagents were applied at the following concen-
trations: 0.5 mM pCMBS- and 2.5 mM MTSEA+. The sulfhydryl reagents
were applied in CFFR solution.
To test the ability of picrotoxin to protect the engineered cysteines from
modification by the sulfhydryl reagents, we used the following sequence of
perfusion solutions: 100 ,uM GABA (10 s), CFFR (3 min), 100 ,uM GABA
(10 s), CFFR (3 min), 100 ,uM picrotoxin + 100 ,uM GABA (1 min),
sulfhydryl reagent + 100 ,uM picrotoxin + 100 ,uM GABA (1 min), CFFR
(3 min), 100 ,uM GABA (10 s), CFFR (3 min) and 100 ,uM GABA (10 s),
and CFFR (3 min) and 100 ,LM GABA (10 s) (see Fig. 5 for example).
Similar results were obtained in four to six oocytes for the mutants
alV257C and a1T261C.
The picrotoxin concentrations that inhibited 50% of the current induced
by 100 ,uM GABA (IC50) and the Hill coefficients for wild type and for the
mutants a1V257C and a1T261C were determined by sequential co-appli-
cation ofGABA and five concentrations of picrotoxin: 1, 5, 10, 50, and 100
,uM. The current was measured after a 20-s co-application of GABA and
picrotoxin.
Statistics
Data in Fig. 3 and 4 are presented as the means ± SE. Significance was
determined by one-way analysis of variance by the Duncan criteria (p <
0.05) using the SPSS-PC statistics program to compare the effect on the
mutants with the effect on wild type.
Sequence alignment
The amino acid sequences of various GABAA receptor subunits in and
flanking the M2 membrane-spanning segment were aligned using the
pileup routine of the GCG package, version 7 (Genetics Computer Group,
Madison, WI).
RESULTS
We mutated, one at a time, five consecutive residues (257 to
261) in the M2 membrane-spanning segment of the rat a1
subunit to cysteine (Fig. 1) and injected mRNA for the
mutant a1 subunit together with mRNA for wild-type 61
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FIGURE 1 The aligned sequences of the amino acid residues (single letter code) in and flanking the M2 membrane-spanning segment of the rat GABAA
receptor a,, f31, and Y2 subunits, the Drosophila GABAA receptor subunit, the rat glycine receptor a, and ,B subunits, and the mouse muscle acetylcholine
receptor a subunit. The upper and lower case italic letters C and c above and below the aligned sequences indicate residues substituted by cysteine in the
GABAA (this report and Xu and Akabas, 1993) and in the acetylcholine receptors (Akabas et al., 1994). Residues shown to be exposed in the channel are
indicated by an upper case C; residues not exposed in the channel are indicated by a lower case c. The M2 segment is underlined; in indicates the
intracellular end; ex indicates the extracellular end. The numbers at the top indicate the residue number of the GABAA receptor al subunit. The alanine
in bold in the Drosophila sequence is mutated to serine in insects resistant to picrotoxin and cyclodiene insecticides (ffrench-Constant et al., 1993a).
and y2 subunits in Xenopus oocytes. All of the mutants
expressed GABA-induced currents one to three days after
injection. We tested the susceptibility of wild-type and
mutant GABAA receptors to irreversible effects of the sulf-
hydryl reagents by a 1-min application of the reagents in the
perfusion solution either in the presence or absence of 100
,M GABA, using two-electrode voltage-clamp recording in
intact oocytes (Fig. 2). In the absence of sulfhydryl reagents,
the GABA-induced currents were stable over the time
course of an experiment. In oocytes expressing wild-type
GABAA receptors, application of either pCMBS- or
MTSEA+, either in the presence or absence of GABA, had
pCMBS
GABA
250 nA
30 SEC
MTSEA
GABA -
500 nA
30 SEC
FIGURE 2 The effect of sulfhydryl reagents applied in the presence of
GABA on the subsequent GABA-induced currents of two cysteine-substi-
tution mutants. In (A) 0.5 mM pCMBS- is applied to the mutant a1V257C,
and in (B) 2.5 mM MTSEA+ is applied to the mutant a1T261C. The
electrical currents recorded by two-electrode voltage clamp from a single
oocyte for each mutant are shown. Two responses to 100 ,uM GABA
precede and two responses follow the 1-min application of the sulfhydryl
reagent + 100 ,LM GABA. Each trace is separated by a 3-5 min perfusion
with CFER Ringers. Solution changes are indicated by the black lines
above each set of traces.
no irreversible effects on the GABA-induced currents (Figs.
3 and 4).
Effect of pCMBS- on the
cysteine-substitution mutants
In the presence of 100 ,uM GABA, a 1-min application of
0.5 mM pCMBS- to the extracellular bath caused signifi-
cant irreversible inhibition of the mutants a1V257C and
alT261C (Figs. 2 A and 3 A).
In the absence of GABA, in the closed state of the
channel, a 1-min application of 0.5 mM pCMBS- to the
extracellular bath caused significant irreversible inhibition
of the mutant alV257C but had no effect on a,T261C (Fig.
3 B). Application of pCMBS-, in the presence or absence of
GABA, had no effect on the mutants aIF258C, ajG259C,
and ajV260C (Fig. 3).
Effect of MTSEA+ on the
cysteine-substitution mutants
A 1-min application of the cationic MTSEA+ to the extra-
cellular bath in the presence or absence of GABA caused
significant irreversible potentiation of the subsequent
GABA-induced currents for the mutant alT261C but had no
effect on the mutant a1V257C (Fig. 2 B and Fig. 4, A and
B). Application of MTSEA+, in the presence or absence of
GABA, also had no effect on the other mutants a1F258C,
aIG259C, and ajV260C (Fig. 4).
Effect of picrotoxin on the accessibility of the
cv1V257C and ot1T261C mutants
The channel-lining residue ajVal257 aligns with the residue
mutated in the Drosophila GABAA receptor from strains
that are resistant to cyclodiene insecticides and picrotoxin
(Fig. 1) (ffrench-Constant et al., 1993a). Co-application of
A
B
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FIGURE 3 The irreversible effect on the GABA-induced currents of wild-type a131B'y2 and the mutants resulting from a 1-min application of 0.5 mM
pCMBS-. (A) pCMBS- applied in the presence of GABA and (B) pCMBS- applied in the absence of GABA. Solid bars indicate mutants for which
inhibition was significantly different (p < 0.05) than for wild type (WT) by one-way analysis of variance. The fractional change was calculated as 1 - (mean
final current/mean initial current). Negative change indicates inhibition, and positive change represents potentiation of the GABA-induced currents
following application of pCMBS-. The means and SEMs are shown. The number of oocytes for each experimental condition is either three or four.
100 ,uM picrotoxin with GABA resulted in complete block
of the GABA-induced current in oocytes expressing wild-
type alV257C or alT261C (Fig. 5, A and B). The block was
reversible, requiring -3-5 min for complete restoration of
the original GABA-induced current. The picrotoxin concen-
trations that inhibited 50% of the current induced by 100
,uM GABA (IC50) and Hill coefficients were 12.3 ± 4.1
,M, nH = 1.0 ± 0.07 (n = 4) for wild type; 4.8 ± 2.0 ,uM,
nH = 0.8 + 0.05 (n = 4) for alT261C; and 4.8 ± 1.0 ,uM,
nH = 0.7 + 0.05 (n = 3) for a1V257C. Thus, the mutations
to cysteine caused only small changes in picrotoxin binding
as measured by inhibition of macroscopic currents.
We examined whether picrotoxin could protect a1V257C
and alT261C from modification by the sulfhydryl reagents.
We co-applied GABA and picrotoxin for 1 min to block
completely all of the GABA-induced current and then added
the sulfhydryl reagent to the perfusion solution with GABA
MTSEA+ + GABA
T261 C
V260C
G259C
F258C
V257C
WT
and picrotoxin for an additional 1 min. The GABA, sulfhy-
dryl reagent, and picrotoxin were washed out, and at 3-min
intervals the magnitude of the GABA-induced current was
tested (Fig. 5 A). In oocytes expressing the mutant
alV257C, the subsequent GABA-induced currents were
similar to their initial levels (Figs. 5 A and 6 A). This
indicates that picrotoxin protected a1V257C from modifi-
cation by pCMBS-. The extent of protection by picrotoxin
was greater when picrotoxin was applied in the presence of
GABA as compared with the absence of GABA (Fig. 6 A);
this is consistent with the use-dependence of the action of
picrotoxin (Newland and Cull-Candy, 1992; Yoon et al.,
1993).
In oocytes expressing the mutant alT261C, co-applica-
tion of picrotoxin did not protect the sulfhydryl from mod-
ification by MTSEA+ (Figs. 5 B and 6 B) or pCMBS- (Fig.
6 C). Furthermore, the reaction of MTSEA+ with alT261C
MTSEA
T261 C
V260C
G259C
F258C
V257C
WT
A
D-
o 20 40 60
B
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IRREVERSIBLE CHANGE IN GABA-INDUCED CURRENT(%)
FIGURE 4 The irreversible effect on the GABA-induced currents of wild-type a%,31y2 and the mutants resulting from a 1-min application of 2.5 mM
MTSEA+. (A) MTSEA+ applied in the presence of GABA and (B) MTSEA+ applied in the absence of GABA. Solid bars indicate mutants for which
inhibition was significantly different (p < 0.05) than for wild type (WT) by one-way analysis of variance. The fractional change was calculated as 1 -
(mean final current/mean initial current). Negative change indicates inhibition, and positive change represents potentiation of the GABA-induced currents
following application of MTSEA+. The means and SEMs are shown. The number of oocytes for each experimental condition is between four and six.
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FIGURE 5 The effect of picrotoxin on the ability of the extracellularly
applied sulfhydryl reagents to react with engineered cysteines exposed in
the channel. Two responses to 100 ,LM GABA precede and three responses
follow the application of sulfhydryl reagent in the presence of 100 ,uM
picrotoxin and 100 ,uM GABA. In (A) 0.5 mM pCMBS is applied to the
mutant a1V257C in the presence of picrotoxin and GABA. The application
of picrotoxin in the presence of GABA completely blocks the GABA-
induced current before pCMBS is applied. Application of pCMBS has no
effect on the subsequent GABA-induced currents. In (B) 2.5 mM MTSEA
is applied to the mutant a1T261C in the presence of picrotoxin and GABA.
The application of picrotoxin in the presence on GABA completely blocks
the GABA-induced current before MTSEA is applied. Note that applica-
tion of MTSEA results in a large increase in the GABA-induced current
even in the continued presence of picrotoxin. The subsequent GABA-
induced currents are larger than the initial currents, indicating potentiation
of the GABA response. The electrical currents recorded by two-electrode
voltage clamp from a single oocyte for each mutant are shown. Each trace
is separated by a 3-min perfusion with CFFR Ringers. Solution changes are
indicated by the black lines above each set of traces.
in the picrotoxin-blocked state relieved the picrotoxin-in-
duced block (Fig. 5 B). Modification of a1T261C by
MTSEA+ increased the IC50 for picrotoxin to 25.4 + 1.3
,uM and reduced the Hill coefficient to 0.47 ± 0.05 (n = 3).
Effects of y-butyrolactone derivatives on
picrotoxin protection of a1V257C
The y-butyrolactone derivative aIMGBL is an antagonist of
the action of picrotoxin (Holland et al., 1990; Yoon et al.,
1993). aIMGBL (5 mM) had no effect on the current
induced by 100 AM GABA (Fig. 7 A; compare the magni-
tude of the initial GABA-induced currents with the initial
peak current during the co-application of the reagents).
Application of pCMBS- in the presence of aIMGBL and
GABA resulted in irreversible inhibition of the subsequent
GABA-induced currents (Fig. 7, A and C). Thus, aIMGBL
by itself did not protect aIV257C from reaction with
pCMBS-.
Co-application of 5 mM aIMGBL, 100 ,uM picrotoxin,
and 100 ,uM GABA resulted in partial block (-30% reduc-
tion) of the GABA-induced current (Fig. 7 B; compare the
magnitude of the initial GABA-induced currents with the
initial peak current during the co-application of the re-
agents). Application of pCMBS- in the presence of
aIMGBL, picrotoxin, and GABA resulted in irreversible
inhibition of the subsequent GABA-induced currents (Fig.
7, B and C). Thus, aIMGBL blocks the ability of picrotoxin
to protect the sulfhydryl from modification.
A second
-y-butyrolactone derivative, ,3EMGBL, partially
blocks GABA-induced currents at low concentrations of
GABA, but BEMGBL had no effect on currents induced by
100 ,uM GABA (Yoon et al., 1993). We found that up to 5
mM ,BEMGBL had no effect on the currents induced by 100
,uM GABA and did not protect the sulfhydryl of alV257C
from reaction with pCMBS- (data not shown). In the pres-
ence of 100 ZM GABA, jEMGBL acted as a picrotoxin
antagonist; co-application of 5 mM f3EMGBL, 100 ,uM
picrotoxin, and 100 ,M GABA resulted in only partial
block (-30% reduction) of the GABA-induced current
(data not shown). Furthermore, application of pCMBS- in
the presence of BEMGBL, picrotoxin, and GABA resulted
in irreversible inhibition of the subsequent GABA-induced
currents, indicating that the sulfhydryl of alV257C was not
protected (data not shown). Thus, in the presence of 100
p,M GABA, ,BEMGBL blocked picrotoxin binding, behav-
ing in a manner similar to aIMGBL.
DISCUSSION
Residues exposed in the channel
The GABA-induced responses of two of the cysteine-sub-
stitution mutants, a1V257C and aIT261C, were irreversibly
altered by the sulfhydryl reagents (Figs. 3 and 4). We infer
that irreversible alteration of the subsequent GABA-induced
responses indicates that the sulfhydryl reagents reacted with
an engineered cysteine. We assume that for cysteine resi-
dues substituted in the M2 membrane-spanning segment,
only those engineered cysteine residues exposed in the
channel lumen will be accessible to react with the charged,
hydrophilic, sulfhydryl reagents added extracellularly. Fur-
thermore, because the mutants displayed responses to
GABA, we assume that the structure of the mutants is
similar to the structure of wild type. Therefore, we infer that
the side chains of the corresponding wild-type residues
a1Val257 and ajThr261 are exposed in the channel. If this
region of the M2 membrane-spanning segment is a-helical,
then ajVal257 and alThr261 would lie on the same side of
an a-helix about 6 A apart.
The residues in the a subunit of the nicotinic acetylcho-
line receptor, Thr244 and Ser248, which align with
ajVal257 and a1Thr261, are also exposed in the channel
lumen (Akabas et al., 1994).
Location of charge-selectivity filter
The GABAA receptor channel is anion selective; the upper
limit of the ratio of potassium permeability relative to
1862 Biophysical Journal
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chloride is 0.05 (Bormann et al., 1987). The ability of the
cationic reagent, MTSEA+, to penetrate from the extracel-
lular end of the channel to the level of a1T261C indicates
that both anions and cations can enter the extracellular end
of the channel. Thus, it is unlikely that the extracellular ring
of charged residues identified by Imoto et al., (1988), which
aligns with GABAA a,Asn275 (Fig. 1), is the only deter-
minant of charge selectivity. Nevertheless, the net positive
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charge on the extracellular ring would tend to concentrate
anions in the mouth of the pore. The charge selectivity filter
appears to be at a position that is more cytoplasmic than
alThr261; however, the small but potentially finite cation
permeability of the GABAA receptor may account for the
ability of MTSEA+ to reach the level of alT261C.
The cation-selective acetylcholine receptor displays a
similar lack of charge selectivity at its extracellular end. We
have previously shown that anionic reagents can enter the
acetylcholine receptor channel to the level of aVal255
(Akabas et al., 1994), which aligns with GABAA receptor
residue ajThr268 (Fig. 1). The substitution of three residues
from the M2 segment of the GABAA receptor, aligned with
al subunit residues Pro253, Ala254, and Thr268, into the
aligned positions in the neuronal a7 acetylcholine receptor
altered the charge selectivity of the substituted acetylcholine
receptor from cation to anion selective (Galzi et al., 1992).
Given that cations can penetrate further into the GABAA
channel than a1Thr268, it seems unlikely that residues at
this level in the channel form part of the charge selectivity
filter.
Location of the gate and structural changes
concomitant with gating
The ability of the sulfhydryl reagents applied in the extra-
cellular bath to react with channel-lining residues in the
absence of GABA, i.e., in the closed state of the receptor,
implies that the channel lumen is patent in the closed state
of the channel from the extracellular end to at least the level
of ajVal257. Furthermore, it implies that the gate, the
structure that blocks ion conduction, is located at least as
close to the cytoplasmic end of the channel as ajVal257 is.
Given the low membrane permeability of pCMBS- (Van-
stevininck et al., 1965) and its ability to distinguish the
sidedness of cysteines in other membrane proteins (Yan and
Maloney, 1993), it is unlikely that it could pass through the
membrane and enter the channel from the cytoplasmic end
to reach ajVal257 in the closed state; similar arguments can
be made for MTSEA+ reaching a,Thr261. Furthermore, if
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FIGURE 6 The effect of picrotoxin on the accessibility of the mutants
a1V257C and a1T261C to modification by sulfhydryl reagents. (A) Picro-
toxin protection of the mutant a1V257C from inhibition by 0.5 mM
pCMBS- applied in the presence or in the absence of 100 ,uM GABA.
Black bars indicate the mean inhibition by pCMBS- applied in the pres-
ence of 100 ,uM picrotoxin; gray bars indicate the mean inhibition by
pCMBS- applied in the absence of picrotoxin. (B) Picrotoxin protection of
the mutant a1T261C from modification by 2.5 mM MTSEA+ applied in
the presence or in the absence of 100 ,uM GABA. Black bars indicate the
mean potentiation by MTSEA+ applied in the presence of 100 ,uM picro-
toxin; gray bars indicate the mean potentiation by MTSEA+ applied in the
absence of picrotoxin. (C) Picrotoxin protection of the mutant a1T261C
from inhibition by 0.5 mM pCMBS- applied in the presence or in the
absence of 100 ,uM GABA. Black bars indicate the mean inhibition by
pCMBS- applied in the presence of 100 ,uM picrotoxin; gray bars indicate
the mean inhibition by pCMBS- applied in the absence of picrotoxin.
Means ± SEM and the number of oocytes for each case are plotted.
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FIGURE 7 The effect of aIMGBL on the accessibility of a1V257C to
reaction with pCMBS- and protection by picrotoxin. (A) The effect of 0.5
mM pCMBS- applied for 1 min in the presence of 5 mM aIMGBL and
100 ,uM GABA on the subsequent GABA-induced currents of the
alV257C mutant. (B) The effect of 0.5 mM pCMBS- applied for 1 min in
the presence of 5 mM cIMGBL, 100 ,uM picrotoxin, and 100 ,uM GABA
on the subsequent GABA-induced currents of the a1V257C mutant. In (A)
and (B), the electrical currents recorded by two-electrode voltage clamp
from single oocytes are shown. Two responses to 100 ,uM GABA precede
and two responses follow the application of reagents + 100 ,uM GABA.
Each trace is separated by a 3-5 min perfusion with CFFR Ringers.
Solution changes are indicated by the black lines above each set of traces.
(C) The average irreversible inhibition of the GABA-induced currents of
the mutant alV257C resulting from a 1-min application of 0.5 mM
pCMBS- in the presence of various reagents. The left bar indicates that
pCMBS- reacts with the mutant and inhibits subsequent GABA-induced
currents. The left center bar indicates that picrotoxin protects the sulfhydryl
of the alV257C mutant from reacting with pCMBS-. The right center bar
indicates that aIMGBL does not protect the sulfhydryl of the aIV257C
mutant from reacting with pCMBS-. The right bar indicates that aIMGBL
blocks the ability of picrotoxin to protect the sulfhydryl of a1V257C. The
mean + SEM and number of oocytes tested are indicated for each condi-
tion.
pCMBS- or MTSEA+ had entered the cytoplasm, with its
high concentration of free sulfhydryls, the sulfhydryl re-
agents would most likely have reacted before they could
enter the cytoplasmic end of the channel.
Our results showing that the gate is at least as cytoplas-
mic as ajVal257 are consistent with the findings of similar
experiments in the acetylcholine receptor which imply that
the gate is located at a position that is even more cytoplas-
mic (Akabas et al., 1994). These results identifying the
position of the gate are inconsistent with the suggestion that
the gate in the acetylcholine receptor is formed by a ring of
leucine residues that align with the GABAA residue
a,Leu264 (Unwin, 1993, 1995).
Although the gate itself is at least as cytoplasmic as or is
more cytoplasmic than ajVal257, the process of gating
appears to cause conformational changes in the channel
lining at more extracellular positions. In the presence of
GABA, both pCMBS- and MTSEA+ react with a1T261C,
but in the absence of GABA only MTSEA+ reacts with
alT261C. The susceptibility of a1T261C to MTSEA+, in
both the presence and absence of GABA, suggests that the
structural change which reduces the susceptibility of this
residue to pCMBS- in the absence of GABA is not due to
the movement of this residue away from the channel lumen
to a buried position. Rather a change in the disposition of
nearby side chains may partially screen the cysteine substi-
tuted for a,Thr261. This may reduce access more for the
larger and more rigid pCMBS- than for MTSEA+. Similar
agonist-induced changes in accessibility have been ob-
served at the more extracellular residue ajThr268 (Xu and
Akabas, 1993) and for some residues in the M2 segment of
the acetylcholine receptor (Akabas et al., 1994).
Site of picrotoxin binding: channel lumen versus
allosteric site
Co-application of picrotoxin protects the sulfhydryl of the
mutant alV257C from modification by pCMBS- (Figs. 5 A
and 6 A) but does not protect the sulfhydryl of the mutant
a1T261C from modification by the charged, sulfhydryl re-
agents (Figs. 5 B and 6, B and C). There are two mecha-
nisms by which picrotoxin could generate a nonconducting
state. Picrotoxin could act as an open channel blocker by
binding in the channel lumen at the level of a,Val257 and
physically preventing access of pCMBS- to the sulfhydryl
of alV257C (Fig. 8 A). Alternatively, the interaction be-
tween picrotoxin and the channel-lining residues may be
allosteric, i.e., picrotoxin binds at a distant site and induces
a conformational change in the receptor driving it into a
nonconducting, blocked state that reduces the accessibility
of the sulfhydryl at a1Val257 but not at a,Thr261 (Fig. 8
B).
The simplest explanation of our results is that picrotoxin
acts as a slowly dissociating, open-channel blocker. The
binding site for picrotoxin would be at the level of
alVal257. Picrotoxin would need to penetrate far enough
into the channel so as not to obstruct the access of sulfhy-
dryl reagents to the more extracellular, adjacent, channel-
lining residue alThr261. The y-butyrolactones presumably
bind in this region and prevent picrotoxin from binding. The
,y-butyrolactones, however, must be small enough to bind
without blocking the channel and therefore do not protect
either a1V257C or a1T261C from modification by the sulf-
hydryl reagents. In addition, because the -y-butyrolactones
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FIGURE 8 Two models for the mechanism of action of picrotoxin are
illustrated. (A) Illustration of an open channel block mechanism where
picrotoxin binds in the channel at the level of a1Val257 and sterically
blocks the channel lumen. (B) Illustration of an allosteric mechanism where
the binding of picrotoxin at a site distant from the channel lumen induces
an occlusion of the pore at the level of a1Val257.
still act on the alV257C and a1T261C mutants, they prob-
ably do not interact strongly with the wild-type residues at
either of these positions.
The site at which picrotoxin binds is only accessible from
the external side of the membrane because cytoplasmic
application of picrotoxin had no effect on GABA-induced
currents (Newland and Cull-Candy, 1992). This implies that
the picrotoxin binding site is most likely on the water-
accessible surface of the protein and that the site is not
accessible from the lipid-protein interface, where the sided-
ness of application should not matter.
If picrotoxin binds in the channel, then the size of picro-
toxin and its ability to protect the sulfhydryl at 257 but not
at 261 may provide insights into the molecular structure of
the channel in this region. Picrotoxinin, the active compo-
nent of picrotoxin, is a compact, rigid, amphipathic mole-
cule that is roughly spherical with a diameter of -9 A,
similar to the length of pCMBS-. The channel diameter
must be sufficiently large to allow picrotoxin to penetrate
from the extracellular end to the level of a1Val257. In the
acetylcholine receptor pore, the narrowest region is thought
to be at the level of the residues aligned with ajVal257
(Villarroel et al., 1991; Cohen et al., 1992). Assuming that
the structures of the GABAA receptor and acetylcholine
receptor channels are similar, then the pore diameter must
decrease in the region of ajVal257. On the basis of the
relative permeabilities of various sized anions, the "effec-
tive pore diameter" of the mouse GABAA receptor channel
at its narrowest point was inferred to be 5.6 A (Bormann et
al., 1987). This diameter is based on the size of the largest
permeant anion; if the permeating anion is partially hy-
drated (a water molecule is -3 A in diameter), the actual
channel diameter would be larger. Thus, the actual channel
diameter may be sufficiently large for picrotoxin, an un-
charged amphipathic molecule, to reach the region of
alVal257.
The residue adjacent to a,Val257 in the channel-lining,
a,Thr261, influences picrotoxin binding. The sulfhydryl in
the a1T261C mutant is not protected by picrotoxin, and
modification by MTSEA+ reduced the affinity for picro-
toxin. If the secondary structure of the M2 segment between
a,Val257 and a1Thr261 is a-helical, then these two resi-
dues would lie on the same side of an a-helix approximately
6 A apart. Given the size of picrotoxin and the estimated
separation of these residues, either a chemically modified
sulfhydryl at position 261 could interact directly with pic-
rotoxin bound in the region of 257 or the chemical modifi-
cation of the sulfhydryl at 261 could induce a propagated
structural perturbation to the region of the picrotoxin bind-
ing site, whether it is at the level of a1Val257 or at a distant
allosteric site. Consistent with these results, mutation of the
residues at the positions aligned with a,Thr261 to phenyl-
alanine in either the a-, 3-, or y subunits abolished picro-
toxin sensitivity (Gurley et al., 1995). The fact that the
comparable mutation in any subunit inhibited picrotoxin
sensitivity is consistent with the picrotoxin binding site
being in the channel lumen. Otherwise, one must assume
that the mutation in any subunit induces a propagated struc-
tural change in all of the subunits to block an allosteric
picrotoxin binding site; this seems unlikely because the
mutant receptors had normal GABA affinity and benzodi-
azepine potentiation, suggesting that the mutations had min-
imal effects on the overall structure of the receptor (Gurley
et al., 1995). Furthermore, homomeric glycine receptors
formed by expression of the a1 subunit are sensitive to
picrotoxin, but glycine receptors formed by co-expression
of the a1 and a subunits are resistant to picrotoxin (Pribilla
et al., 1992). There are several differences in the sequence
of the M2 segment of the glycine receptor f3 subunit that
might be responsible for the picrotoxin resistance, notably a
proline at the position aligned with a,Val257 and a phenyl-
alanine at the position aligned with alThr261 (Fig. 1).
Drosophila resistant to cyclodiene insecticides and picro-
toxin have a point mutation of alanine to serine at residue
302 in the GABAA receptor a subunit. This residue aligns
with the channel-lining residue Val257 in the rat a1 subunit
(Fig. 1). Picrotoxin inhibits wild-type Drosophila GABAA
receptors with an IC50 of - 1 tM; the A302S mutation
reduces the picrotoxin sensitivity by 100-fold (ffrench-Con-
stant et al., 1993a). The A302S mutant is also reported to
stabilize the open state relative to the desensitized state
(Zhang et al., 1994). The presence of a serine at this level in
the channel does not prevent picrotoxin binding because
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there is a serine in the rat y2 subunit at the aligned position
(Fig. 1); however, the subunit stoichiometry of the rat and
Drosophila GABAA receptors, and thus the number of
serines at this position in the two receptors, is unknown.
Nevertheless, the fact that resistance to picrotoxin and in-
secticide is conferred by a mutation in Drosophila GABAA
receptor of a residue that we have shown is exposed in the
channel supports the interpretation that picrotoxin binds in
the channel.
The interaction between the picrotoxin binding site and
GABA binding is complicated. With the use of 15-min
incubations, the presence or absence of GABA did not
affect the binding of [3H]dihydropicrotoxinin to rat brain
membranes (Ticku et al., 1978). In electrophysiologic ex-
periments, the binding of picrotoxin is use-dependent, i.e.,
picrotoxin binds more rapidly to the GABA-bound open
state than to the closed state (Smart and Constanti, 1986;
Inoue and Akaike, 1988; Twyman et al., 1989; Newland and
Cull-Candy, 1992; Yoon et al., 1993); however, it does bind
to the closed state of the receptor, although at a much slower
rate (Newland and Cull-Candy, 1992). The binding of [35S]_
t-butylbicyclophosphorothionate ([35S]-TBPS) to GABAA
receptors is competitively blocked by picrotoxin, is anion-
dependent, and is inhibited by GABA (Squires et al., 1983).
This suggests that the TBPS binding site partially overlaps
the picrotoxin site, but TBPS must interact with other res-
idues that undergo a conformational change following
GABA binding. Similarly, the binding site of the y-butyro-
lactones used in this study presumably partially overlaps the
picrotoxin and TBPS sites. As with TBPS, the inhibitory
effects of ,BEMGBL are inhibited by GABA (Yoon et al.,
1993). Thus, the binding of GABA must alter the structure
of the GABAA receptor in the region surrounding the pic-
rotoxin binding site, both to account for the use-dependence
of picrotoxin-induced block and to account for the inhibi-
tion of TBPS and ,BEMGBL binding. We have shown that
the accessibility of alT261C is different in the presence and
absence of GABA. This implies that GABA binding in-
duces a conformational change in the channel lining in the
region of 257-261. These GABA-induced changes may
account for the use-dependence of picrotoxin block and the
inhibition of TBPS binding by GABA.
Although all of the above results are compatible with the
picrotoxin binding site being in the channel at the level of
ajVal257, the results above could also be interpreted with
an allosteric model assuming close coupling between a
distant picrotoxin binding site and the region of the channel
that we have studied. In view of the allosteric coupling
between various other GABAA receptor modulators such as
benzodiazepines, barbiturates and neurosteroids, we cannot
at present rule out the possibility that picrotoxin blocks
conduction by an allosteric mechanism, although it seems
less likely. If picrotoxin were to act by an allosteric mech-
anism, it could not act by simply locking the receptor in the
closed state; in the closed state alV257C was accessible to
pCMBS-, but in the picrotoxin-blocked state the sulfhydryl
at position a1Val257 was inaccessible to pCMBS-.
CONCLUSIONS
In conclusion, the structure of the GABAA receptor channel
in the region of residues a1257 to a1261 appears to be
important for several aspects of channel function. We have
identified ajVal257 and a,Thr261, two residues in this
region that line the channel of the GABAA receptor. The
channel lining undergoes a structural change during gating,
but the gate is at least as cytoplasmic as ajVal257. The
charge selectivity filter appears to be between positions 261
and 257 because the positively charged sulfhydryl reagent
reacted with a sulfhydryl at the level of a,Thr261 but not at
the level of ajVal257. Furthermore, we have shown that
picrotoxin block of GABA-induced currents may result
from picrotoxin binding in the channel lumen at the level of
ajVal257.
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